Moderately Severe Hemophilia B
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB16791 | Etranacogene dezaparvovec | An adeno-associated virus vector-based gene therapy used for the treatment of hemophilia B (congenital factor IX deficiency). |
| DB16783 | Fidanacogene elaparvovec | In Canada and the US, fidanacogene elaparvovec is indicated for the treatment of adults (aged 18 years or older) with moderately severe to severe Hemophilia B (congenital Factor IX deficiency)... |
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|